Ayurveda supplement for Sickle Cell Anemia

A clinical study on Dadimadi Avaleha as palliative care in childhood sickle cell anemia - DA - SCA

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/03/040875

Enrollment

Registered

2022-03-07

Start date

Unknown

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D758- Other specified diseases of bloodand blood-forming organs

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients with sign and symptoms of sickle cell anaemia like pallor fatigue pain loss of appetite etc Patients with positive sickling test Hb >6.5% and Pre diagnosed cases with SCA will be taken only

Exclusion criteria

Exclusion criteria: Patients with Hepatic Renal Dysfunction Chronic Cardiac Dysfunction SCA associated with other diseases like Diabetes Mellitus Hypertension Thalassemia Hb 11.5% During the study if any crisis or complication occurs the patients will be discontinued from study

Design outcomes

Primary

Measure	Time frame
Improvement in Quality of life Improvement in Hb percentageTimepoint: At base line 4 weeks and 8 weeks and 12 weeks	—

Secondary

Measure	Time frame
Prevention of episodes of sickling Reduction in spleenomegalyTimepoint: 60 days 60 days	—

Countries

India

Contacts

Public ContactDr Swapnil C Raskar

Parul Institute of Ayurved

neonatecare99@gmail.com

Outcome results